Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
07 Aug 2020
Historique:
entrez: 10 8 2020
pubmed: 10 8 2020
medline: 15 8 2020
Statut: ppublish

Résumé

Macrophage activation syndrome (MAS) is a rare life-threatening condition characterized by cytokine-mediated tissue injury and multiorgan dysfunction. We describe the unique case of young man who developed MAS as the sole manifestation of an otherwise paucisymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Clinical and biological criteria led to the diagnosis of MAS; cytokine profile was highly suggestive reverse transcription polymerase chain reaction for SARS-CoV-2 in nasopharyngeal swabs was negative, but serum anti-SARS-CoV-2 immunoglobulin A and immunoglobulin G resulted positive leading to the diagnosis of SARS-CoV-2 infection. The patient was treated with empiric antibiotic and hydroxychloroquine. Clinical improvement ensued. At follow-up, the patient is well. SARS-CoV-2 infection may trigger develop life-threatening complications, like MAS. This can be independent from coronavirus disease 2019 gravity.

Identifiants

pubmed: 32769902
doi: 10.1097/MD.0000000000021570
pii: 00005792-202008070-00043
pmc: PMC7593078
doi:

Substances chimiques

DNA, Viral 0
Hydroxychloroquine 4QWG6N8QKH
Ceftriaxone 75J73V1629

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21570

Références

Lupus. 2018 Jun;27(7):1065-1071
pubmed: 29451069
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101515
pubmed: 32387063
Front Med (Lausanne). 2020 Apr 24;7:184
pubmed: 32391371
Lancet. 2020 May 22;:
pubmed: 32450107
Best Pract Res Clin Rheumatol. 2014 Apr;28(2):277-92
pubmed: 24974063
Arthritis Rheumatol. 2014 Sep;66(9):2613-20
pubmed: 24782338
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265

Auteurs

Sanaz Lolachi (S)

Division of General Internal Medicine, Department of Medicine.

Sarah Morin (S)

Hematology Division, Department of Oncology, Geneva University Hospitals.

Matteo Coen (M)

Division of General Internal Medicine, Department of Medicine.
University of Geneva, Faculty of Medicine, Unit of Development and Research in Medical Education (UDREM).

Kaveh Samii (K)

Hematology Division, Department of Oncology, Geneva University Hospitals.

Alexandra Calmy (A)

Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.

Jacques Serratrice (J)

Division of General Internal Medicine, Department of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH